Japanese nation-wide prospective observational study on the current state and efficacy of therapeutics for large vessel vasculitis, -Takayasu's arteritis and Giant cell arteritis
Not Applicable
- Conditions
- arge Vessel Vasculitis (Takayasu's arteritis, Giant cell arteritis)
- Registration Number
- JPRN-UMIN000010414
- Lead Sponsor
- The Specified Disease Treatment Research Program
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) the patients with Buerger's disease 2) the patients with malignant disease 3) the patients who their primary doctors consider as inappropriate 4) the patients who disagree to participate in this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the remission rate of Takayasu's arteritis and Giant cell arteritis
- Secondary Outcome Measures
Name Time Method 1) survival rate 2) cause of death 3) responder rate of the therapy 4) relapse rate 5) incidence rate of the infectious disease and the analysis of its risk factor 6) concordance rate of current diagnostic criteria and classification of large vessel vasculitis 7) pathological condition of Takayasu's arteritis and Giant cell arteritis 8) identification of the candidate of new biomaker of large vessel vasculitis 9) identification of the new diagnostic imaging method